Insights for Management of Ground-Glass Opacities From the National Lung Screening Trial
- 1 September 2019
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 14 (9) , 1662-1665
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
This publication has 14 references indexed in Scilit:
- Influence of lung nodule margin on volume- and diameter-based reader variability in CT lung cancer screeningBritish Journal of Radiology, 2018
- Lung-RADS: Pushing the LimitsRadioGraphics, 2017
- Disagreement of diameter and volume measurements for pulmonary nodule size estimation in CT lung cancer screeningThorax, 2017
- The relationship of cancer characteristics and patient outcome with time to lung cancer diagnosis after an abnormal screening CTEuropean Radiology, 2017
- Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelinesEuropean Radiology, 2017
- Solitary Pure Ground-Glass Nodules 5 mm or Smaller: Frequency of GrowthRadiology, 2015
- Performance of Lung-RADS in the National Lung Screening TrialAnnals of Internal Medicine, 2015
- Subcentimeter lung nodules stable for 2 years at LDCT: Long‐term follow‐up using volumetryRespirology, 2014
- Probability of Cancer in Pulmonary Nodules Detected on First Screening CTNew England Journal of Medicine, 2013
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011